Fate Therapeutics FATE
NASDAQ FATE
$1.61 -0.16 (-9.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Fate Therapeutics (FATE) Preferred Stock Liabilities (2012 - 2026)

Updated

Fate Therapeutics (FATE) posted Preferred Stock Liabilities of $56.53 million for Q3 2013.

Analysis

Fate Therapeutics (FATE) Preferred Stock Liabilities (2012 - 2026) Analysis & Trends

  • In prior years, Fate Therapeutics' Preferred Stock Liabilities was $50.31 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Fate Therapeutics 215.18 Mn 76.08 Mn - 13.78 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 13.78 Bn
Jun 30, 2026 13.78 Bn
Mar 31, 2026 13.78 Bn
Sep 30, 2025 13.78 Bn
Jun 30, 2025 13.78 Bn
Mar 31, 2025 13.78 Bn
Dec 31, 2013 56.53 Mn
Sep 30, 2013 56.53 Mn
Dec 31, 2012 56.53 Mn
API Access

Fate Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=FATE&period=max&api_key=YOUR_API_KEY